DEUTSCHE BANK AG\ - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 60 filers reported holding LOGICBIO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$78,000
-13.3%
10,714
-8.6%
0.00%
Q4 2020$90,000
+40.6%
11,721
+66.5%
0.00%
Q3 2020$64,000
+16.4%
7,040
+9.1%
0.00%
Q2 2020$55,000
+292.9%
6,455
+126.7%
0.00%
Q1 2020$14,000
-63.2%
2,847
-48.3%
0.00%
Q4 2019$38,000
+58.3%
5,503
+128.5%
0.00%
Q3 2019$24,000
-71.1%
2,408
-63.1%
0.00%
Q2 2019$83,000
-16.2%
6,526
-36.1%
0.00%
Q1 2019$99,000
-13.9%
10,212
-8.7%
0.00%
Q4 2018$115,00011,1880.00%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Orbimed Advisors 8,466,783$5,758,0000.09%
HARBOR CAPITAL ADVISORS, INC. 226,731$154,0000.07%
Sio Capital Management, LLC 182,630$124,0000.04%
Virtu Financial LLC 71,475$49,0000.00%
Independence Bank of Kentucky 10,200$7,0000.00%
SANDERS MORRIS HARRIS LLC 15,000$10,0000.00%
Endurance Wealth Management, Inc. 1,500$12,0000.00%
Baker Brothers Advisors 451,478$307,0000.00%
Texas Yale Capital Corp. 20,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 79,900$54,0000.00%
View complete list of LOGICBIO THERAPEUTICS INC shareholders